• Glomerular Basement Membrane Antibody, IgG
  • Chlamydia trachomatis NAAT, Urine
  • WIPF1 Gene Mutation Analysis
  • Phosphorylated tau 217 (pTau 217), Plasma, (Quest AD-Detect®, ALZpath pTau217)
  • Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
  • Viral hepatitis
  • Benign neoplasm, uterine cervix
  • Malignant neoplasm, uterine cervix (cervical cancer)
  • Nefazodone, Urine
  • G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /ROMA Score for Ovarian Cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

ROMA Score for Ovarian Cancer Risk Assessment
Medical Test

Turnaround Time
Access to ROMA Score for Ovarian Cancer Risk Assessment is restricted.
Loading...